News Article
New GLP1R insights may lead to better diabetes therapies
31 Jan 2020

Glucagon-like peptide-1 receptor (GLP1R) has been more extensively characterised using advanced imaging techniques, which may aid in the development of better diabetes therapies, according to a study published in Nature Communications

Medical News Today